Is GSK plc (GSK) stock halal?

No. GSK plc fails Shariah screening — see the screen table and analysis on this page for the specific business-activity or ratio reasons.

Does GSK plc pass the AAOIFI financial ratio screen?

As of 2026-03-31: interest-bearing debt is 31.8% of market cap (limit < 30%); cash plus interest-bearing securities is 5.7% (limit < 30%). The impermissible-income line is verified against the annual filing where noted on this page.

Is GSK plc held in halal ETFs like SPUS or HLAL?

Check the scholar/screener positions and sources on this page for current SPUS, HLAL, Zoya, and Musaffa statuses.

Is GSK Stock Halal? GSK plc (GSK) does not pass Shariah screening: interest-bearing debt / market cap is 31.8% against the < 30% limit (data as of 2026-03-31). Screened alternatives exist in the same sector — see the halal stock screeners and ETF guides below. Reviewed 2026-06-15. Published by HalalWallet.

Is GSK Stock Halal?

Q: Is GSK Stock Halal?

Not Halal: GSK plc (GSK) does not pass Shariah screening: interest-bearing debt / market cap is 31.8% against the < 30% limit (data as of 2026-03-31). Screened alternatives exist in the same sector — see the halal stock screeners and ETF guides below. (Financial data as of 2026-03-31; basis: AAOIFI Shariah standards.)

Q: Is GSK plc held in halal ETFs like SPUS or HLAL?

Check the scholar/screener positions and sources on this page for current SPUS, HLAL, Zoya, and Musaffa statuses.

GSK plc · GSK · NYSE

Not HalalNot permissible

GSK plc (GSK) does not pass Shariah screening: interest-bearing debt / market cap is 31.8% against the < 30% limit (data as of 2026-03-31). Screened alternatives exist in the same sector — see the halal stock screeners and ETF guides below.

Financial data as of 2026-03-31 · Screening basis: AAOIFI · Last reviewed 2026-06-15

Our Analysis

GSK plc is a publicly traded company in its sector. Review the latest 10-K segment disclosure for revenue mix.

Financial ratios drive the fail (data as of 2026-03-31): interest-bearing debt / market cap at 31.8% versus the < 30% limit.

Zoya's public page did not return a clear status when we checked (checked 2026-06-15). Musaffa rates it doubtful. U.S. Shariah ETFs SPUS and HLAL publish holdings on their own schedules — absence from a top-holdings list is not the same as a failed screen; verify current ETF holdings if index validation matters to you.

Practical takeaway: do not treat this as a borderline hold — the fail is structural on our methodology. Use Shariah-screened ETFs (SPUS, HLAL) or individually screened peers in the same sector instead.

Investors should treat this page as one dated AAOIFI-based screen — not a personal fatwa — and verify the latest filing before trading.

Business Activity Screen

Pass· impermissible revenue ≈ 0.2% (AAOIFI limit < 5%)

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The

Interest income $56.0M on $32.67B total revenue (GSK plc FY2025 (fiscal year ended 2025-12-31, Form 10-K)) = 0.2% — under AAOIFI's 5% limit.

Financial Ratio Screen

Screen	Value	AAOIFI limit	Result
Interest-bearing debt / market cap	31.8%	< 30%	Fail
Cash + interest-bearing securities / market cap	5.7%	< 30%	Pass
Impermissible income / total revenueInterest income $56.0M on $32.67B total revenue (GSK plc FY2025 (fiscal year ended 2025-12-31, Form 10-K)) = 0.2% — under AAOIFI's 5% limit.	0.2%	< 5%	Pass

Spot market cap at research date (consider trailing average for borderline names). Data as of 2026-03-31 · thresholds per AAOIFI Shariah standards.

This verdict uses the AAOIFI standard — the most widely used and, at a 30% debt limit, the most conservative mainstream Shariah standard. Interest-bearing debt and interest-bearing securities each stay under 30% of market cap, and impermissible income under 5% of revenue. Other standards (Dow Jones Islamic, S&P Shariah, MSCI Islamic, FTSE Yasaar) use ~33% limits or screen against total assets, so a borderline company can be rated differently by each. How we screen & why screeners disagree →

How GSK screens across Shariah standards

The standards disagree on this company. It passes some Shariah screens and fails others — which is exactly why you may see a different answer in different apps. Our headline verdict uses AAOIFI, the strictest and most widely cited mainstream standard.

Standard	Debt	Cash & interest securities	Limit / basis	Result
AAOIFI (our standard)	31.8%	5.7%	< 30% of market cap	Fail
Dow Jones Islamic / S&P Shariah thresholdDow Jones and S&P apply this limit against a trailing 24–36-month average market cap; shown here on the same point-in-time market cap for comparison.	31.8%	5.7%	< 33% of market cap	Pass
MSCI Islamic / FTSE Yasaar basisTotal-assets denominator. MSCI/FTSE also apply entry/exit buffers and a receivables screen we do not reproduce.	30.3%	5.5%	< 33.33% of total assets	Pass

HalalWallet computation reproducing each standard's threshold and denominator from public filings (balance sheet as of 2026-03-31) — not the providers' licensed index determinations, which can differ. Debt is interest-bearing borrowings (operating leases excluded). The impermissible-income screen (< 5% of revenue) is common to all of these standards and is shown in the ratio table above. Dow Jones and S&P apply their limit against a trailing 24–36-month average market cap; MSCI and FTSE add entry/exit buffers and a receivables screen. Full methodology →

These companies pass under some mainstream standards and fail under others — the same pattern as this verdict. That is why two apps can show different answers.

AbbVieABBV